Present situation and progress in research on HIV/AIDS laboratory testing

Chinese Journal of Evidence-Based Medicine

Volumn 8, Issue 3, 2008, Pages 206-209

  Bai, Lang ^a   Lei, Bing Jun ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Acquired immunodeficiency syndrome; Human immunodeficiency virus; Laboratory testing

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BIOTECHNOLOGY; FALSE NEGATIVE RESULT; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; IMMUNOLOGY; LABORATORY TEST; MEDICAL RESEARCH; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION;

EID: 51349135544     PISSN: 16722531     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Mylonakis E, Paliou M, Lally M, et al. Laboratory testing for infection with the human immunodeficiency virus:established and novel approaches. Am J Med, 2000, 109(7): 568-576.
2. Gurtler L, Muhlbacher A, Michl U, et al. Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay. J Virol Methods, 1998, 75(1): 27-38.
3. Weber B, Berger A, Rabenau H, et al. Evaluation of a New Combined Antigen and Antibody Human Immunodeficiency Virus Screening Assay , VIDAS HIV DUO Ultra. J Clin Microbiol, 2002, 40(4): 1420-1426.
4. Weber B, Gürtler L, Thorstensson R, et al. Multicenter Evaluation of a New Automated Fourth-generation Human Immunodeficiency Virus Screening Assay with a sensitive Antigen Detection Module and High Specificity. J Clin Microbiol, 2002, 40(6): 1938-1946.
5. Gurtler LG, Eberle J, Lorbeer B, et al. Sensitivity and specificity of commercial ELISA kits for screening anti-LAV/HTLV III. J Virol Methods, 1987, 15(1): 11-23.
6. Petricciani JC, Epstein JS. The effects of the AIDS epidemic on the safety of the nation's blood supply. Public Health Rep, 1988, 103(3): 236-241.
7. Barbe F, Klein M, Badonnel Y. Early detection of antibodies to human immunodeficiency virus 1 by a third-generation enzyme immunoassay.A comparative study with the results of second-generation immunoassays and western blot. Ann Biol Clin(Paris), 1994, 52(5): 341-345.
8. Suligoi B, Galli C, Massi M, et al. Precision and Accuracy of a Procedure for Detecting Recent Human Immunodeficiency Virus Infections by Calculating the Antibody Avidity Index by an Automated Immunoassay-Based Method. J Clin. Microbiol, 2002, 40(11): 4015-4020.
9. Ly TD, Laperche S, Brennan C, et al. Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays. J Virol Methods, 2004, 122(2): 185-194.
10. Bernard M Branson, MD. Rapid Test for HIV Antiboby. AIDS Reviews, 2000, 2: 76-83.
11. Chinese source
12. Chinese source
13. Chinese source
14. Chinese source
15. Nguyen KA, Busch MP. Evolving strategies for diagnosing human immunodeficiency virus infection. Am J Med, 2000, 109(7): 595-597.
16. Celum CL, Coombs RW, Jones M, et al. Risk factors for repeatedly reactive HIV-1 EIA and indeterminate western blots. A population-based case-control study. Arch Intern Med, 1994, 154(5): 1129-1137.
17. Riddler S, Mellors JW. Clinical use of Viral Load Measures. MMWR, April,1998. 18 2003, 10(4): 111-114.
18. Chinese source
19. Chinese source
20. Mellors JW, Rinaldo CR, Gupta P, et al. Prognosis in HIV-1 Infection Predicted by the Quantity of virus in plasma. Science, 1996, 272(5): 1167.
21. Lindback S, Karlsson AC, Mittler J, et al. Viral dynamics in primary HIV-1 infection. AIDS, 2000, 14(15): 2283-2291.
22. + Lymphocytes as Prognostic Markers of HIV-1 Infection. Ann Intern Med, 1997, 126: 946-954.
23. Abravaya K, Esping C, Hoenle R, et al. Performance of a Multiplex Qualitative PCR LCx Assay for Detection of Human Immunodeficiency Virus Type 1 (HIV-1) Group M Subtypes, Group O, and HIV-2. J Clin Microbiol, 2000, 38(2): 716-723.
24. Zhao YQ, Min Y, Miller JW, et al. Quantification of Human Immundeficiency virus type 1 Proviral DNA by Using TaqMan Technology. J Chin Microbiol, 2002, 40(2): 675-678.
25. Leroy V, Montcho C, Manigart O, et al. Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial. AIDS, 2001, 15(4): 517-522.
26. +T cells changes in patients failing potent protease inhibitor therapy. Presented at the 5th Conference on Retroviruses and Opportunistic Infections; February 1-5, 1998; Chicago. Abstract 419.
27. Chinese source
28. Edelstein RE, Nickerson DA, Tobe VO, et al. Oligonucleotide Ligation Assay for Detecting Mutations in the Human Immunodeficiency Virus Type 1 pol Gene That Are Associated with Resistance to Zidovudine, Didanosine, and Lamivudine. J Clin Microbiol, 1998, 36(7): 569-572.